ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert McKenna Named New President Of Society Of Surgical Oncology, Hiram Polk President Elect

May 13, 1983

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983